Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)
Latest Information Update: 03 Sep 2020
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 04 Sep 2018 Planned End Date changed from 1 Aug 2013 to 1 Sep 2020.
- 04 Sep 2018 Planned primary completion date changed from 1 Apr 2013 to 1 Sep 2020.
- 27 Aug 2012 New trial record